SCHEMBL2592834

SCHEMBL2592834

CCC(C)/C=C/C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2592835 1.00
SCHEMBL18753087 1.00
SCHEMBL34468196 0.84 EGFR (0.35)
SCHEMBL34468172 0.82 EGFR (0.38)
SCHEMBL34468179 0.82 EGFR (0.38)
SCHEMBL13604724 0.82 EGFR (0.38)
SCHEMBL5666704 0.81 CHRM1 (0.36)
SCHEMBL809574 0.81 CHRM1 (0.36)
SCHEMBL814572 0.81 CHRM1 (0.36)
SCHEMBL11764159 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-219441659-U Unsaturated ketone preparation ware 山东新和成维生素有限公司 2023-08-01 CN disclosed
US-9018382-B2 Indazoles GLAXOSMITHKLINE LLC (US) 2015-04-28 US disclosed
US-9018382-B2 Indazoles GLAXOSMITHKLINE LLC (US) 2015-04-28 US disclosed
US-9018382-B2 Indazoles GLAXOSMITHKLINE LLC (US) 2015-04-28 US disclosed
EP-2566328-B1 INDAZOLES GLAXOSMITHKLINE LLC (US) 2015-03-04 EP disclosed
EP-2566328-B1 INDAZOLES GLAXOSMITHKLINE LLC (US) 2015-03-04 EP disclosed
US-20140350013-A1 INDAZOLES GLAXOSMITHKLINE LLC 2014-11-27 US disclosed
US-20140350013-A1 INDAZOLES GLAXOSMITHKLINE LLC 2014-11-27 US disclosed
US-20140350013-A1 INDAZOLES GLAXOSMITHKLINE LLC 2014-11-27 US disclosed
US-8846935-B2 Indazoles GLAXOSMITHKLINE LLC (US) 2014-09-30 US disclosed
WO-2011140325-A1 INDAZOLES GLAXOSMITHKLINE LLC (US) 2011-11-10 WO disclosed
WO-2011140325-A1 INDAZOLES GLAXOSMITHKLINE LLC (US) 2011-11-10 WO disclosed
US-20100137318-A1 BICYCLIC HETEROCYCLIC COMPOUND ONO PHARMACEUTICAL CO., LTD. (JP) 2010-06-03 US disclosed
EP-2154139-A1 BICYCLIC HETEROCYCLIC COMPOUND ONO Pharmaceutical Co., Ltd. (JP) 2010-02-17 EP disclosed
US-5484949-A Method for the synthesis of α β-unsaturated ketones NIPPON SODA CO., LTD. (JP) 1996-01-16 US disclosed
EP-0454867-A1 A METHOD FOR THE SYNTHESIS OF -g(a), -g(b)-UNSATURATED KETONES. NIPPON SODA CO (JP) 1991-11-06 EP disclosed
WO-1991007370-A1 A METHOD FOR THE SYNTHESIS OF α, β-UNSATURATED KETONES NIPPON SODA CO., LTD. (JP) 1991-05-30 WO disclosed
EP-0044413-B1 3,6-DIMETHYL-OCT-1-IN-3-OLS AND -OCT-1-EN-3-OLS AND DERIVATIVES THEREOF, THEIR USE AS FRAGRANCES AND PROCESS FOR PREPARING 3,6-DIMETHYL-OCTAN-3-OL BASF Aktiengesellschaft (DE) 1984-02-15 EP disclosed
US-4347388-A 3,6-Dimethyl-3-hydroxy-oct-1-ynes and -oct-1-enes, derivatives of these, and their use as scents, and in the preparation of 3,6-dimethyl-3-hydroxy-octane BASF AKTIENGESELLSCHAFT (DE) 1982-08-31 US disclosed
EP-0044413-A1 3,6-Dimethyl-oct-1-in-3-ols and -oct-1-en-3-ols and derivatives thereof, their use as fragrances and process for preparing 3,6-dimethyl-octan-3-ol BASF Aktiengesellschaft (DE) 1982-01-27 EP disclosed